期刊文献+

婴儿白血病临床分析 被引量:1

Clinical Characteristics of Infantile Acute Leukemia
原文传递
导出
摘要 目的探讨婴儿急性白血病(IAL)的临床与实验室检查特征。方法对1999年12月-2011年6月收治的15例婴儿急性白血病的临床资料进行总结与分析。结果其中急性淋巴细胞白血病(ALL)6例,急性髓系白血病(AML)8例,分类不明1例,其中以M4(4例)、M5(3例)为主。临床表现多样,髓外浸润明显。1例细胞形态学与免疫分型有差异,1例合并染色体异常。放弃治疗者11例,死亡2例,正规治疗的2例于诱导缓解后获完全缓解。结论 IAL预后差,需完善相关检查并不断总结临床资料以提高IAL治愈率。 Objective To observe the clinical and laboratory features of infantile acute leukemia. Methods We respectively reviewed and analyzed the clinical and laboratory data of 15 patients from December 1999 to June 2011. Results In the 15 patients, 6 were acute lymphoblastic leukemia, 8 were acute myeloid leukemia, and the classification of leukemia of the rest one was unknown; among whom, the M4 (4 cases) and M5 (3 cases) subtypes were the most common types, comprising 50% and 37.5% of AML respectively. The clinical manifestations of IAL were various with obviously extramedullary infiltrations. Of all the patients, one case was not consistent with its immunophenotype in cell morphology and one infant had chromosomal abnormality. Two cases died of infections and intracranial hemorrhage before chemotherapy. Eleven patients gave up the chemotherapy and only two achieved complete remission after induction chemotherapy. Conclusion Infantile acute leukemia (IAL) has poor prognosis, therefore, improving the relevant laboratory tests and effective treatment of IAL is important.
出处 《华西医学》 CAS 2012年第10期1487-1490,共4页 West China Medical Journal
关键词 婴儿 急性白血病 诊断 治疗 Infants Acute leukemia Diagnosis Therapy
  • 相关文献

参考文献13

二级参考文献49

  • 1马晓莉,吴敏媛,胡亚美.婴儿急性白血病的生物学进展[J].临床血液学杂志,2005,18(4):247-250. 被引量:6
  • 2顾龙君,马志贵,李筏骏,顾梅榆,董硕,陈静,姚惠玉,陈赛娟,陈竺.婴儿急性白血病HRX基因重排及其意义[J].中华儿科杂志,1995,33(5):261-263. 被引量:2
  • 3马志贵,黄秋花,董硕,曹琪,苏欣莹,黄薇,王振义,顾龙君,陈赛娟,陈竺.急性白血病HRX基因重排的研究[J].中华血液学杂志,1996,17(1):3-6. 被引量:1
  • 4吴梓梁.小儿急性淋巴细胞白血病的治疗现状与推广经济治疗方案的必要性[J].新医学,2006,37(9):563-564. 被引量:8
  • 5Kawasaki H, Isoyama K, Eguchi M, et al. Superior outcome of infant acute myeloid leukemia with intensive chemotherapy : results of the Japan Infant Leukemia Study Group. Blood, 2001 ;98 (13): 3589-3594.
  • 6Ishii E, Kawasaki H, Isoyama K, et al. Recent advances in the treatment of infant acute myeloid leukemia. Leuk Lymphoma, 2003 ;44 ( 5 ) : 741-748.
  • 7Pui CH, Raimondi SC, Srivastava DK, et al. Prognostic factors in infants with acute myeloid leukemia. Leukemia, 2000; 14 (4): 684-687.
  • 8Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia ( Interfant-99 ) : an observational study and a multicentre randomised trial. Lancet, 2007 ;370(9583) :240-250.
  • 9Dordelmann M, Reiter A, Borkhardt A, et al. Prednisone Response Is the Strongest Predictor of Treatment Outcome in Infant Acute Lymphoblastic Leukemia. Blood, 1999 ; 194 (4) : 1209-1217.
  • 10Nagayama J, Tomizawa D, Koh K, et al. Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results from the Japan Infant Leukemia Study Group. Blood, 2006 ; 107 (12) :4663-4665.

共引文献18

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部